Attention deficit hyperactivity disorder (ADHD).
Conditions
Interventions
Intervention 1: In intervention group, 50000 IU pearl of vitamin D administered weekly for six weeks. The serum levels of vitamin D are evaluated at baseline and after eight weeks. The ADHD developmen
Treatment - Drugs
Placebo
In intervention group, 50000 IU pearl of vitamin D administered weekly for six weeks. The serum levels of vitamin D are evaluated at baseline and after eight weeks. The ADHD development is assessed by
In intervention group, 50000 IU pearl of vitamin D placebo administered weekly for six weeks. The serum levels of vitamin D are evaluated at baseline and after eight weeks. The ADHD development is ass
Sponsors
Drug Applied Research Center, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion: children age between 2-18 years Exclusion: anticonvulsant, corticosteroids, supplements which contains vitamin D consumption chronic disease
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vitamin D level. Timepoint: 8 weeks. Method of measurement: blood sample. | — |
Secondary
| Measure | Time frame |
|---|---|
| Factors related to severity of ADHD. Timepoint: 8 weeks. Method of measurement: Coners checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaba Ghaffary
Tabriz University of Medical Sciences
Outcome results
None listed